Nonlegal, judicial, and statutory courses of action are available to patient surrogates and physicians who cannot agree on withdrawal of life-sustaining treatment.
When patients request drugs for nonmedical reasons, the most effective intervention may be to explore with the patient his or her reasons for using drugs to make lifestyle changes.
Clinical trials for the blood substitute PolyHeme exposed the possibility for ambiguous interpretation of the FDA’s waiver of informed consent for emergency research.
William Heisel, an investigative reporter with the Los Angeles Times, is interviewed about how medicine and the media can work better together to provide accurate and responsible health news to the public.
Physicians should be aware when developing a treatment plan that patients' lack of trust in the medical profession can affect their willingness to seek medical treatment and comply with the treatment.
Guidelines exist for delivery-room treatment for newborns at the margins of viability, and when the rules and limits are reached, parental values are important.
Guidelines exist for delivery-room treatment for newborns at the margins of viability, and when the rules and limits are reached, parental values are important.
Physicians should fully understand the ethical principles and professional standards involved in making decisions for the treatment of impaired newborns.